Physical exercise antagonizes clinical and anatomical features characterizing Lieber-DeCarli diet-induced obesity and related metabolic disorders

Clinical Nutrition

Volumn 34, Issue 2, 2015, Pages 241-247

  Gonçalves, Inês O ^a   Passos, Emanuel ^b   Rocha Rodrigues, Sílvia ^a   Torrella, Joan R ^c   Rizo, David ^c   Santos Alves, Estela ^a   Portincasa, Piero ^d   Martins, Maria J ^b   Ascensão, António ^a   Magalhães, José ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Body composition; Liver; NASH; Physical activity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDURANCE TRAINING; FEMUR; HEART; HISTOPATHOLOGY; INTRAABDOMINAL FAT; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; LIVER; MALE; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PRIMARY PREVENTION; RAT; SEDENTARY LIFESTYLE; THERAPY EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; ADVERSE EFFECTS; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; KINESIOTHERAPY; MOTOR ACTIVITY; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; EXERCISE THERAPY; INTRA-ABDOMINAL FAT; LIVER; MALE; MOTOR ACTIVITY; NON-ALCOHOLIC FATTY LIVER DISEASE; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 84924612859     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.03.010     Document Type: Article

References (36)

1. Maziak W., Ward K.D., Stockton M.B. Childhood obesity: are we missing the big picture?. Obes Rev 2008, 9:35-42. England.
2. Ross R., Dagnone D., Jones P.J., Smith H., Paddags A., Hudson R., et al. Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial. Ann Intern Med 2000, 133(2):92-103.
3. Pedersen B.K., Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports 2006, 16(Suppl.1):3-63. Denmark.
4. Lieber C.S., Leo M.A., Mak K.M., Xu Y., Cao Q., Ren C., et al. Model of nonalcoholic steatohepatitis. Am J Clin Nutr 2004, 79(3):502-509.
5. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41(6):1313-1321.
6. Knight J.A. Diseases and disorders associated with excess body weight. Ann Clin Lab Sci 2011, 41:107-121. United States.
7. Bray G.A., Paeratakul S., Popkin B.M. Dietary fat and obesity: a review of animal, clinical and epidemiological studies. Physiol Behav 2004, 83:549-555. United States.
8. Hill J.O., Peters J.C., Lin D., Yakubu F., Greene H., Swift L. Lipid accumulation and body fat distribution is influenced by type of dietary fat fed to rats. Int J Obes Relat Metab Disord 1993, 17(4):223-236.
9. Wang Y., Ausman L.M., Greenberg A.S., Russell R.M., Wang X.D. Nonalcoholic steatohepatitis induced by a high-fat diet promotes diethylnitrosamine-initiated early hepatocarcinogenesis in rats. Int J Cancer 2009, 124(3):540-546.
10. Estrany M.E., Proenza A.M., Llado I., Gianotti M. Isocaloric intake of a high-fat diet modifies adiposity and lipid handling in a sex dependent manner in rats. Lipids Health Dis 2011, 10:52. England.
11. Knight J.A. Physical inactivity: associated diseases and disorders. Ann Clin Lab Sci 2012, 42:320-337. United States.
12. He Y., Zhang H., Fu F. The effects of swimming exercise on high-fat-diet-induced steatohepatitis. JSports Med Phys Fit 2008, 48(2):259-265.
13. Marques C.M., Motta V.F., Torres T.S., Aguila M.B., Mandarim-de-Lacerda C.A. Beneficial effects of exercise training (treadmill) on insulin resistance and nonalcoholic fatty liver disease in high-fat fed C57BL/6 mice. Braz J Med Biol Res 2010, 43(5):467-475.
14. Gauthier M.S., Couturier K., Latour J.G., Lavoie J.M. Concurrent exercise prevents high-fat-diet-induced macrovesicular hepatic steatosis. JAppl Physiol 2003, 94(6):2127-2134.
15. Irving B.A., Davis C.K., Brock D.W., Weltman J.Y., Swift D., Barrett E.J., et al. Effect of exercise training intensity on abdominal visceral fat and body composition. Med Sci Sports Exerc 2008, 40(11):1863-1872.
16. Takahashi Y., Soejima Y., Fukusato T. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2012, 18(19):2300-2308.
17. Deng Q.G., She H., Cheng J.H., French S.W., Koop D.R., Xiong S., et al. Steatohepatitis induced by intragastric overfeeding in mice. Hepatology 2005, 42(4):905-914.
18. Promrat K., Kleiner D.E., Niemeier H.M., Jackvony E., Kearns M., Wands J.R., et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010, 51(1):121-129.
19. Bhat G., Baba C.S., Pandey A., Kumari N., Choudhuri G. Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease. World J Hepatol 2012, 4(7):209-217.
20. Grattagliano I., de Bari O., Bernardo T.C., Oliveira P.J., Wang D.Q., Portincasa P. Role of mitochondria in nonalcoholic fatty liver disease-from origin to propagation. Clin Biochem 2012, 45(9):610-618.
21. Amir M., Czaja M.J. Autophagy in nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol 2011, 5(2):159-166.
22. Ni H.M., Williams J.A., Yang H., Shi Y.H., Fan J., Ding W.X. Targeting autophagy for the treatment of liver diseases. Pharmacol Res 2012, 66:463-474.
23. Serviddio G., Bellanti F., Sastre J., Vendemiale G., Altomare E. Targeting mitochondria: a new promising approach for the treatment of liver diseases. Curr Med Chem 2010, 17(22):2325-2337.
24. Wang Y., Ausman L.M., Russell R.M., Greenberg A.S., Wang X.D. Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax. JNutr 2008, 138(10):1866-1871.
25. Abdelmegeed M.A., Yoo S.H., Henderson L.E., Gonzalez F.J., Woodcroft K.J., Song B.J. PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver. JNutr 2011, 141(4):603-610.
26. Dowman J.K., Tomlinson J.W., Newsome P.N. Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2011, 33(5):525-540.
27. Conigrave K.M., Davies P., Haber P., Whitfield J.B. Traditional markers of excessive alcohol use. Addiction 2003, 98(Suppl.2):31-43. (Abingdon, England).
28. Kunde S.S., Lazenby A.J., Clements R.H., Abrams G.A. Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology 2005, 42(3):650-656.
29. Fracanzani A.L., Valenti L., Bugianesi E., Andreoletti M., Colli A., Vanni E., et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 2008, 48(3):792-798.
30. Shi J.P., Xun Y.H., Hu C.B., Zhang L., Liu H., Lou G.Q., et al. Clinical and histological features of non-alcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi 2009, 17(11):812-816.
31. Fujita K., Nozaki Y., Wada K., Yoneda M., Fujimoto Y., Fujitake M., et al. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology 2009, 50(3):772-780.
32. Papandreou D., Karabouta Z., Rousso I. Are dietary cholesterol intake and serum cholesterol levels related to nonalcoholic fatty liver disease in obese children?. Cholesterol 2012, 2012:572820.
33. Zhang L., Geng Y., Xiao N., Yin M., Mao L., Ren G., et al. High dietary n-6/n-3 PUFA ratio promotes HDL cholesterol level, but does not suppress atherogenesis in apolipoprotein E-null mice 1. JAtheroscler Thromb 2009, 16:463-471. Japan.
34. Kucera O., Garnol T., Lotkova H., Stankova P., Mazurova Y., Hroch M., et al. The effect of rat strain, diet composition and feeding period on the development of a nutritional model of non-alcoholic fatty liver disease in rats. Physiol Res 2011, 60:317-328. Czech Republic.
35. Goncalves I.O., Oliveira P.J., Ascensao A., Magalhaes J. Exercise as a therapeutic tool to prevent mitochondrial degeneration in nonalcoholic steatohepatitis. Eur J Clin Invest 2013, 43(11):1184-1194.
36. Sullivan S., Kirk E.P., Mittendorfer B., Patterson B.W., Klein S. Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease. Hepatology 2012, 55(6):1738-1745.